Meadow Creek Wealth Advisors LLC cut its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 3.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,082 shares of the financial services provider’s stock after selling 109 shares during the quarter. Meadow Creek Wealth Advisors LLC’s holdings in CME Group were worth $716,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Truvestments Capital LLC bought a new stake in CME Group in the third quarter worth $26,000. SJS Investment Consulting Inc. increased its position in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares during the last quarter. Dunhill Financial LLC increased its position in shares of CME Group by 188.4% during the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares during the last quarter. Financial Life Planners bought a new position in CME Group in the fourth quarter worth approximately $32,000. Finally, Fortitude Family Office LLC raised its holdings in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 83 shares during the period. Institutional investors own 87.75% of the company’s stock.
Analyst Upgrades and Downgrades
CME has been the topic of a number of research reports. Keefe, Bruyette & Woods reduced their price target on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating on the stock in a report on Monday, January 13th. Piper Sandler increased their price target on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft decreased their price objective on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Oppenheimer raised their target price on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Finally, Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $255.00 to $250.00 in a research report on Monday, January 6th. Four investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $229.27.
CME Group Stock Down 0.4 %
Shares of NASDAQ:CME opened at $241.64 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $249.02. The stock has a market cap of $87.08 billion, a price-to-earnings ratio of 25.41, a price-to-earnings-growth ratio of 5.37 and a beta of 0.57. The firm’s 50 day moving average price is $235.11 and its 200 day moving average price is $223.36.
CME Group Increases Dividend
The firm also recently declared a dividend, which was paid on Thursday, January 16th. Investors of record on Friday, December 27th were issued a $5.80 dividend. This is an increase from CME Group’s previous dividend of $2.50. The ex-dividend date was Friday, December 27th. CME Group’s dividend payout ratio is 48.37%.
CME Group announced that its Board of Directors has initiated a share repurchase plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its shares are undervalued.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Russell 2000 Index, How Investors Use it For Profitable Trading
- 3 Must-Have ETFs Set to Dominate This Quarter
- Manufacturing Stocks Investing
- Seeking Stability? These 3 Stocks Offer Strong Potential
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.